Table 2.

Studies comparing NIPPV and NCPAP.

References	n	Synchoniz-ation	Surfactant prior	GA, weeks	Intubation/respiratory failure	Death	BPD
Armanian et al. (60)	98	No	No	<35	4 vs. 2	4 vs. 2	n/a
Bisceglia et al. (61)	88	No	No	28–34	2 vs. 2	0 vs. 0	4 vs. 8
Kirplani et al. (62)	185	Some	No	<30	21 vs. 29	3 vs. 4	19 vs. 14
Meneses et al. (63)	200	No	No	26–33	58 vs. 64	22 vs. 26	26 vs. 25
Kugelman et al. (64)	84	Yes	No	24–34	25 vs. 46*	0 vs. 0	2 vs. 17*
Sai Sunil Kishore et al. (65)	76	No	Some	28–34	19 vs. 41*	13 vs. 23	3 vs. 10
Salama et al. (66)	60	Yes	Some	28–34	10 vs. 20	0 vs. 3	3 vs. 6
Lista et al. (67)	40	Yes	Yes	28–34	10 vs. 15	0 vs. 0	0 vs. 0
Ramanathan et al. (68)	110	No	Yes	26–29	17 vs. 42*	2 vs. 2	22 vs. 39
Oncel et al. (69)	200	No	No	26–32	13 vs. 29*	4 vs. 6	7 vs. 16*

NIPPV, Nasal intermittent positive pressure ventilation; NCPAP, Nasal continuous positive pressure ventilation.

^*p < 0.05.